Praxair reported third-quarter net income down 10%, to $318 million ($1.02/share), excluding a $7-million tax benefit, on sales down 20%, to $2.3 billion. Sales rose 7% sequentially. Operating profit...
This information is only available to subscribers.
chemweek.com is the one stop platform for chemical news, data and analysis across all industry sectors and geographies.